In fact, we expected a p-Akt down-regulation, at least after prolonged 24 h treatment similar to Chen and coworkers, who observed a p-Akt down-regulation at 2.5 μM Ouabain in U-87 GBM cells [46]. The gene discussed is AKT1; the disease is glioblastoma.